Pacer Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Buy |
64,632
+47,329
| +274% | +$1.31M | ﹤0.01% | 1054 |
|
|
2025
Q1 | $491K | Sell |
17,303
-9,473
| -35% | -$269K | ﹤0.01% | 1434 |
|
|
2024
Q4 | $1.11M | Sell |
26,776
-20,901
| -44% | -$869K | ﹤0.01% | 1287 |
|
|
2024
Q3 | $3.19M | Buy |
47,677
+2,379
| +5% | +$159K | 0.01% | 774 |
|
|
2024
Q2 | $5.38M | Buy |
45,298
+3,930
| +10% | +$467K | 0.01% | 555 |
|
|
2024
Q1 | $4.41M | Sell |
41,368
-4,024
| -9% | -$429K | 0.01% | 602 |
|
|
2023
Q4 | $4.51M | Sell |
45,392
-7,951
| -15% | -$791K | 0.01% | 590 |
|
|
2023
Q3 | $5.51M | Sell |
53,343
-27,538
| -34% | -$2.84M | 0.02% | 448 |
|
|
2023
Q2 | $9.83M | Sell |
80,881
-18,448
| -19% | -$2.24M | 0.04% | 384 |
|
|
2023
Q1 | $15.3M | Sell |
99,329
-1,126,738
| -92% | -$173M | 0.07% | 293 |
|
|
2022
Q4 | $220M | Buy |
1,226,067
+57,020
| +5% | +$10.2M | 1.13% | 8 |
|
|
2022
Q3 | $138M | Buy |
1,169,047
+149,879
| +15% | +$17.7M | 0.96% | 23 |
|
|
2022
Q2 | $146M | Buy |
1,019,168
+438,198
| +75% | +$62.6M | 1.08% | 10 |
|
|
2022
Q1 | $100M | Buy |
580,970
+465,401
| +403% | +$80.2M | 0.82% | 12 |
|
|
2021
Q4 | $29.4M | Buy |
115,569
+83,543
| +261% | +$21.2M | 0.3% | 45 |
|
|
2021
Q3 | $12.3M | Sell |
32,026
-43,512
| -58% | -$16.7M | 0.16% | 141 |
|
|
2021
Q2 | $17.8M | Buy |
75,538
+61,087
| +423% | +$14.4M | 0.25% | 56 |
|
|
2021
Q1 | $1.89M | Sell |
14,451
-1,064
| -7% | -$139K | 0.03% | 532 |
|
|
2020
Q4 | $1.62M | Sell |
15,515
-13,985
| -47% | -$1.46M | 0.03% | 508 |
|
|
2020
Q3 | $2.09M | Buy |
29,500
+29,190
| +9,416% | +$2.07M | 0.04% | 401 |
|
|
2020
Q2 | $20K | Buy |
+310
| New | +$20K | ﹤0.01% | 875 |
|